Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D
NCT06783088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-12-23
Summary
The main of this study is to demonstrate the feasibility of carrying out quantitative acquisitions regardless of the energy peak considered (113 keV (kiloelectronVolts) or 208 keV or a combination of the 2 energy peaks). A study on phantom will optimise the reconstruction parameters. These parameters will then be applied to a population of patients who have already benefited from a recording on a 3D CZT camera (retrospective data).
Conditions
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-10
- Primary Completion
- 2025-04-10
- Completion
- 2025-05-12
Countries
- France
Study Locations
More Related Trials
-
Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer
NCT02516995 ·Status: COMPLETED ·Phase: NA
-
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
NCT06700057 ·Status: RECRUITING
-
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer
NCT04443062 ·Status: COMPLETED ·Phase: PHASE2
-
C-arm Cone-beam CT in Prostate Brachytherapy
NCT02322931 ·Status: UNKNOWN ·Phase: NA
-
Identifying Prostate Brachytherapy Seeds Using MRI
NCT01878058 ·Status: COMPLETED ·Phase: NA
-
The Radium-select Study
NCT06659926 ·Status: RECRUITING ·Phase: NA
-
Artificial Intelligence & Prostate Cancer
NCT06298305 ·Status: COMPLETED
-
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers
NCT01205321 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
NCT07054346 ·Status: RECRUITING ·Phase: PHASE1
-
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
NCT05570994 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
NCT05603559 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Radioligand fOr locAl raDiorecurrent proStaTe cancER
NCT05230251 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer
NCT04632251 ·Status: UNKNOWN ·Phase: NA
-
Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy
NCT06268418 ·Status: COMPLETED
-
Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.
NCT06136377 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer
NCT06201741 ·Status: RECRUITING ·Phase: NA
-
uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
NCT02964988 ·Status: TERMINATED ·Phase: PHASE2
-
Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer
NCT03443609 ·Status: COMPLETED ·Phase: NA
-
99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
NCT06419348 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer
NCT06105918 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study
NCT06830408 ·Status: COMPLETED
-
Hypofractionated Radiotherapy for Prostate Cancer
NCT02311049 ·Status: COMPLETED ·Phase: PHASE2
-
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
NCT05867615 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
177Lu-labeled NY108 SPECT Imaging in Patients
NCT05815394 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer
NCT03326440 ·Status: COMPLETED ·Phase: NA